Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fortrea Holdings Inc. (FTRE) and Lexeo Therapeutics, Inc. (LXEO)
Fortrea Holdings Inc. Announces New Principal Accounting Officer
Express News | Fortrea Appoints Robert Parks as Chief Accounting Officer
Evercore Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $31
Evercore analyst Elizabeth Anderson CFA maintains $Fortrea Holdings(FTRE.US)$ with a buy rating, and maintains the target price at $31.According to TipRanks data, the analyst has a success rate of 37.
Express News | Fortrea Has Launched Its Artificial Intelligence Innovation Studio To Develop And Deploy Ai And Machine Learning Technologies For Clinical Research Process
Express News | Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
Fortrea to Participate in Virtual Fireside Chat With Evercore ISI
DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will participate in a virtual
Fortrea Holdings(FTRE.US) Officer Buys US$50,600 in Common Stock
$Fortrea Holdings(FTRE.US)$ Officer Hanson James S. purchased 2,000 shares of common stock on Jun 12, 2024 at an average price of $25.3 for a total value of $50,600.Source: Announcement What is statem
Stocks With the Highest and Lowest Liquidity - Goldman Sachs
Fortrea Holdings Initiated at Neutral by Goldman Sachs
Fortrea Holdings Initiated at Neutral by Goldman Sachs
Goldman Sachs Initiates Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $28
Goldman Sachs analyst Matthew Sykes initiates coverage on $Fortrea Holdings(FTRE.US)$ with a hold rating, and sets the target price at $28.According to TipRanks data, the analyst has a success rate of
Express News | Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
Fortrea to Present at the Jefferies Global Healthcare Conference
DURHAM, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial
Gildan Activewear, Fortrea Holdings See Activist Investor Action -- Barrons.com
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequen
Fortrea Holdings Inc (FTRE) CEO Acquires Additional Shares
Fortrea Holdings(FTRE.US) Officer Buys US$248.07K in Common Stock
$Fortrea Holdings(FTRE.US)$ Officer Pike Thomas purchased 10,000 shares of common stock on May 29, 2024 at an average price of $24.8066 for a total value of $248.07K.Source: Announcement What is state
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trialsDURHAM, N.C., May 30, 2024 (G
Express News | Fortrea Holdings Inc : TD Cowen Initiates Coverage With Hold Rating; Target Price $27
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Fortrea Holdings Inc. (FTRE) and Cellectis SA (CLLS)
Express News | Starboard Value LP - Had Previously Reported 6.9% Stake in Fortrea Holdings as of Feb 22, 2024